These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10460943)

  • 1. Effect of amlodipine therapy on the monoclonal antibody 3G8-induced calcium signal in polymorphonuclear leukocytes of hemodialysis patients.
    Ahmed A; Krol E; Smogorzewski M; Massry SG
    Am J Nephrol; 1999; 19(4):505-8. PubMed ID: 10460943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine reverses the elevation in [Ca2+]i and the impairment of phagocytosis in PMNLs of NIDDM patients.
    Krol E; Agueel R; Banue S; Smogorzewski M; Kumar D; Massry SG
    Kidney Int; 2003 Dec; 64(6):2188-95. PubMed ID: 14633142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the effect of nifedipine therapy and its discontinuation on [Ca2+]i and phagocytosis of polymorphonuclear leukocytes from hemodialysis patients.
    Alexiewicz JM; Smogorzewski M; Gill SK; Akmal M; Massry SG
    Am J Nephrol; 1997; 17(1):12-6. PubMed ID: 9057947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone.
    Massry S; Smogorzewski M
    Kidney Int Suppl; 2001 Feb; 78():S195-6. PubMed ID: 11169010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment of hemodialysis patients with nifedipine on metabolism and function of polymorphonuclear leukocytes.
    Alexiewicz JM; Smogorzewski M; Klin M; Akmal M; Massry SG
    Am J Kidney Dis; 1995 Mar; 25(3):440-4. PubMed ID: 7872322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired phagocytosis in dialysis patients: studies on mechanisms.
    Alexiewicz JM; Smogorzewski M; Fadda GZ; Massry SG
    Am J Nephrol; 1991; 11(2):102-11. PubMed ID: 1951470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of enhanced neutrophil cytosolic free calcium of hemodialysis patients by 1,25-dihydroxyvitamin D3 or calcium channel blocker.
    Haag-Weber M; Mai B; Hörl WH
    Am J Nephrol; 1993; 13(6):467-72. PubMed ID: 8141182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function.
    Alexiewicz JM; Kumar D; Smogorzewski M; Klin M; Massry SG
    Ann Intern Med; 1995 Dec; 123(12):919-24. PubMed ID: 7486486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats.
    Seyrek N; Marcinkowski W; Smogorzewski M; Demerdash TM; Massry SG
    Nephrol Dial Transplant; 1997 Feb; 12(2):265-72. PubMed ID: 9132643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study on the effect of nifedipine therapy and its discontinuation on [Ca2+]i and proliferation of B lymphocytes of dialysis patients.
    Alexiewicz JM; Smogorzewski M; Akmal M; Massry SG
    Am J Kidney Dis; 1997 Feb; 29(2):233-8. PubMed ID: 9016895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients.
    Hörl WH; Haag-Weber M; Mai B; Massry SG
    Kidney Int; 1995 Jun; 47(6):1741-5. PubMed ID: 7643544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
    Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
    Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Masaki M; Mano T; Eguchi A; Fujiwara S; Sugahara M; Hirotani S; Tsujino T; Komamura K; Koshiba M; Masuyama T
    Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet effect on polymorphonuclear leucocytes of kidney transplant patients.
    Cohen G; Raupachova J; Borchhardt K; Hörl WH
    Eur J Clin Invest; 2013 May; 43(5):476-82. PubMed ID: 23521420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.
    MacGregor MS; Deighan CJ; Rodger RS; Boulton-Jones JM
    Nephron Clin Pract; 2005; 101(3):c139-49. PubMed ID: 16015004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated iron metabolism in patients on hemodialysis.
    Nakanishi T; Hasuike Y; Otaki Y; Nanami M; Kuragano T
    Contrib Nephrol; 2015; 185():22-31. PubMed ID: 26023012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine reverses the abnormalities in [Ca2+]i and proliferation of B cells from dialysis patients.
    Alexiewicz JM; Smogorzewski M; Akmal M; Klin M; Massry SG
    Kidney Int; 1996 Oct; 50(4):1249-54. PubMed ID: 8887284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.